Bio-Rad Announces Financial Results for the First Quarter of 2025 Bio-Rad Laboratories, Inc. , a global leader in life science research and clinical diagnostics, released its financial results for the…
Crown Bioscience and NEXT Oncology Expand Strategic Partnership In a significant development that reinforces their shared vision for transforming cancer research and drug development, Crown Bioscience, a global contract research…
Genmab to Submit sBLA to FDA for Epcoritamab Combo in Relapsed/Refractory Follicular Lymphoma Genmab A/S, a leading international biotechnology company specializing in the development of antibody therapeutics for the treatment…
PCI Pharma Acquires Ajinomoto Althea as Part of $1B Investment to Boost U.S. Aseptic Fill-Finish Capacity PCI Pharma Services, a globally recognized contract development and manufacturing organization (CDMO) specializing in…
Sapient Unveils DynamiQ Next-Gen Data Insights Engine for Drug Discovery and Development Sapient, a pioneering leader in multi-omics data generation and clinical insights, has unveiled its next-generation multi-omics and real-world…
Predicta Biosciences Unveils First Molecular Diagnostic for Enhancing Multiple Myeloma Prognosis Predicta Biosciences, a precision oncology company, has officially launched its first Laboratory Developed Test (LDT), GenoPredicta, a cutting-edge diagnostic…
Verily Wins Michael J. Fox Foundation Grant to Build Major Parkinson’s Molecular Dataset In a significant development for neurodegenerative disease research, Verily, the Alphabet-owned precision health technology company, announced today…
Sunflower Therapeutics Announces Sales Agreement with Optimal Biotech Group Sunflower Therapeutics, a public benefit corporation with a mission to transform global access to protein manufacturing capacity, has taken a significant…
Tranont Adds Metabolic Health Expert Dr. Erin Glynn to Advisory Board In a bold move that underscores its continued investment in science-driven wellness and product development, Tranont, a company known…
Glaukos Reports Financial Results for First Quarter 2025 Glaukos Corporation , a global ophthalmic pharmaceutical and medical technology innovator, delivered a powerful performance in the first quarter of 2025, signaling…
Henry Meds Launches Personalized Hormone Therapies for Menopause Relief Henry Meds, a fast-growing innovator in the telehealth sector, announced a major expansion of its healthcare offerings today with the launch…
Pilatus Biosciences Unveils Preclinical Data on CD36 Antibody PLT012 for Liver Cancer Pilatus Biosciences, a biotechnology company dedicated to developing next-generation immunometabolic therapies for cancer, has announced the publication of…